Human's best science for human's best friend
Please include your email.
Future Equity Agreement (SAFE)
We’re developing a cost effective cell therapy to cure cancer in dogs. It's proven in humans. We've built our MVP and showed it's safe in dogs. We treat cancer patients in August! We're a team of world leading experts in gene editing, immunotherapy, and veterinary oncology. We use CRISPR to genetically engineer T cells, making them cancer fighting machines. We’re backed by Y Combinator W19. Other alumni include Ginkgo Bioworks, Atomwise, Science Exchange.
Have you done enough research to provide a rating? This is important for your fellow investors.
We only allow one revision to each rating category. Be sure about any changes.
No reports have been submitted
Contact support@crowdlustro.com if you need assistance.
Your experience on this site will be improved by allowing cookies.